TB-500: Every Question You've Had, Answered Simply
TB-500 is a synthetic peptide fragment used for injury recovery, tissue repair, and healing. It's drawn from positions 17-23 of thymosin beta-4, a protein your body makes naturally. Here are the questions that keep coming up, answered without the jargon.
What does TB-500 actually do in the body?
It grabs onto a protein called G-actin and holds it in a free, unpolymerized state. That sounds technical, but the practical effect is simple: cells can move faster. When tissue is damaged, your repair cells need to travel to the injury site. TB-500 speeds that migration up, which means collagen gets laid down sooner, new blood vessels form faster, and inflammation clears more quickly.
Why do athletes use TB-500?
Two reasons. First, it works systemically. One injection reaches every injury in your body at the same time. Second, it doesn't require you to inject near the injury. For a torn hip flexor or a damaged shoulder, getting a needle close to the problem is difficult or painful. TB-500 goes in the abdomen and still reaches the target tissue through circulation.
Is TB-500 the same as thymosin beta-4?
No. Thymosin beta-4 is 43 amino acids long. TB-500 is just 7 of those amino acids, the segment responsible for binding actin. Full-length thymosin beta-4 has additional regions that activate other repair pathways TB-500 can't replicate. Most clinical studies cited in support of TB-500 were actually run on the full protein, not the fragment.
A 2024 paper by Rahaman et al. added another complication: TB-500 may metabolize in the body into an even smaller molecule called Ac-LKKTE, and that metabolite may be doing much of the work. The full picture is still being worked out.
How long before TB-500 starts working?
Most people notice anti-inflammatory effects (less swelling, less stiffness) within the first week. Pain during movement often improves noticeably by week 3-4. For tendons and ligaments, the structural repair that makes a real difference takes 6-10 weeks minimum. Tendon tissue has poor blood supply; even with enhanced angiogenesis, it heals slowly.
Expecting results at week 2 in a chronic tendon injury is the most common source of premature disappointment with this peptide.
What dose should I take?
The community standard for a loading phase is 2-2.5 mg injected subcutaneously, twice per week (Monday/Thursday or Tuesday/Friday). That runs for 4-6 weeks depending on injury severity. Maintenance follows at 2 mg once weekly until the end of the cycle, typically 8-12 weeks total.
Body weight is not the main dosing variable. Injury severity and how chronic the problem is matter more.
Does the injection need to go near the injury?
No. That's one of the functional differences between TB-500 and BPC-157. Because TB-500 acts systemically, the lower abdomen, outer thigh, or upper arm all work equally well regardless of where the injury is. The peptide distributes through circulation and gets to the target site on its own.
What's the cancer concern about?
TB-500 promotes angiogenesis, the growth of new blood vessels. Tumors also depend on angiogenesis to grow beyond a certain size. The theoretical concern is that TB-500 could accelerate blood vessel growth into an existing undetected tumor.
No human study has documented TB-500 causing cancer. No standard-dose animal study has either. The concern is mechanistically logical but not supported by clinical evidence. Anyone with an active malignancy, a suspected tumor, or a recent cancer history should not use it.
Can TB-500 help with old, chronic injuries?
Yes, and chronic injuries are actually one of the better use cases. Tissue that's been damaged for months or years has often lost capillary density. Blood supply to the area diminishes over time. TB-500's angiogenic effect rebuilds that local circulation, which re-opens the repair pathway that had gone quiet. A 6-week loading phase (rather than 4) is standard for chronic presentations, and a 12-week cycle is common.
How do I know if my TB-500 is real?
Ask for a COA (Certificate of Analysis) from an independent third-party lab. It should include:
HPLC purity at ≥98% (≥99% is the quality standard)
Mass spectrometry confirming the molecular weight matches Ac-LKKTETQ (799.93 Da)
Endotoxin testing showing <1.0 EU/mg
Lot number and testing date
If the COA comes from the manufacturer rather than an independent lab, it's self-certification, not verification. Price under $20/vial for 5 mg typically means the product is underdosed, impure, or untested.
Is TB-500 legal to buy?
In the US, yes. It's not a scheduled controlled substance and there's no law against purchasing it. It's sold as a research chemical. The FDA removed it from the Category 2 compounding restriction list in April 2026 after nominators withdrew. A PCAC committee review in July 2026 will determine whether licensed compounding pharmacies can produce it again by prescription.
For competitive athletes: TB-500 is on the 2026 WADA Prohibited List under Section S2 (growth factors). A positive test carries a minimum two-year ban. Detection window in urine and blood is roughly 30-45 days.
Can you stack TB-500 with BPC-157?
Yes, and many people do. BPC-157 delivers a localized healing signal near the injection site; TB-500 delivers a systemic one across the whole body. Together they cover both angles. BPC-157 goes in near the injury daily at 250-500 mcg; TB-500 goes in the abdomen twice weekly at 2-2.5 mg. Never mix them in the same vial.
What should I watch out for when buying TB-500?
No COA on the product page (red flag)
COA testing done in-house by the vendor (not independent)
No mass spectrometry listed, only HPLC purity
Price below $25 for a 5 mg vial
Vague product descriptions or "TB-500 blend" labeling
The quality gap in the research peptide market is real. A vial labeled 5 mg may contain significantly less. Dosing math is pointless if the starting material is inaccurate.
Where can I read the detailed protocols?
Full loading phase tables, injury-specific protocols, the Wolverine stack breakdown, and a COA verification checklist are at onpeps.com, sourced from peer-reviewed literature throughout.
